Drug Target Review2025-12-01T08:30:13
Scientists have used human stem cell–derived kidney organoids to uncover how abnormal Hippo signalling drives scarring in nephronophthisis, a rare genetic kidney disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2023-03-30T09:15:30
Sponsored by Halo Labs
2023-02-03T13:56:13
Sponsored by Leica Microsystems
2023-02-23T14:02:18
Sponsored by bit.bio
2026-08-06T06:08:00
Author Dr Jonathan Cohen-Gold
2026-09-30T13:00:00
Sponsored by Sartorius
2026-09-23T15:00:00
Sponsored by BioIVT
Site powered by Webvision Cloud